TRGel develops glucose-based biopolymers that can be used instead of calcium alginate for encapsulation.
TRGel develops glucose-based biopolymers that can be used instead of calcium alginate for encapsulation. The company was founded in 2010 and is based in Irvine, California.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 15, 2021 | Grant | $256K | 1 |
National Science Foundation
|
— | Detail |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
National Science Foundation
|
Yes | Grant |